financetom
Business
financetom
/
Business
/
Mobileye Global's Non-Chinese Partnerships Still Valuable; Likely to See Growth in 2025, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mobileye Global's Non-Chinese Partnerships Still Valuable; Likely to See Growth in 2025, UBS Says
Oct 4, 2024 10:31 AM

12:36 PM EDT, 10/04/2024 (MT Newswires) -- Mobileye Global's ( MBLY ) partnerships with non-Chinese automakers still hold value, but a return to growth is likely pushed to 2025 with significant negative revisions expected in revenue forecasts for 2025 through 2027, UBS Securities said in a note Friday.

The company's growth story, which was heavily reliant on its advanced SuperVision system, has faced significant delays as Zeekr opted for an in-house solution and there are volume concerns from other customers like FAW and Polestar, according to the note.

"We do not see SuperVision re-acceleration until 2026 when the Volkswagen Group award should begin," UBS added.

The investment firm said it could change its neutral stance on Mobileye if there is evidence of faster adoption of its advanced products, driven by legacy automakers aiming to compete with Tesla (TSLA) and Chinese original equipment manufacturers.

UBS downgraded its rating on the company's stock to neutral from buy and reduced the price target to $14 from $20.

The rating downgrade is driven by underperformance, market appreciation of the company's challenges, and longer-term uncertainties, UBS said.

Mobileye shares were up 4% in recent trading.

Price: 12.89, Change: +0.49, Percent Change: +4.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tanzanian LNG project delayed as government seeks to change terms
Tanzanian LNG project delayed as government seeks to change terms
May 6, 2024
LONDON, May 6 (Reuters) - Negotiations for the development of Tanzania's $42 billion liquefied natural gas export plant have been delayed by proposed government changes to a financial agreement reached last year, a government spokesperson and two company sources said. The government and investors announced last May they had completed negotiations on the long-delayed project to unlock Tanzania's vast offshore...
Mastercard, Visa Sued by Luxury Brands Empire LVMH, The Telegraph Reports
Mastercard, Visa Sued by Luxury Brands Empire LVMH, The Telegraph Reports
May 6, 2024
04:00 AM EDT, 05/06/2024 (MT Newswires) -- Luxury brands empire LVMH has launched a series of legal complaints against Mastercard ( MA ) and Visa (V) in Britain's High Court, The Telegraph reported Saturday. Details of the cases have not yet been made public. However, the reported legal action comes as retailers such as LVMH, owner of Louis Vitton and...
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca
May 6, 2024
04:22 AM EDT, 05/06/2024 (MT Newswires) -- Cellectis ( CLLS ) said Monday that AstraZeneca ( AZN ) has completed an additional equity investment of $140 million in the company, after clearance from the French Ministry of Economy. AstraZeneca ( AZN ) has subscribed for 10 million class A convertible preferred shares and 18 million class B convertible preferred shares...
KKR to Acquire Healthium for Undisclosed Sum
KKR to Acquire Healthium for Undisclosed Sum
May 6, 2024
04:14 AM EDT, 05/06/2024 (MT Newswires) -- KKR & Co ( KKR ) said Monday it has signed definitive agreements under which funds managed by the company will acquire Indian medical devices company Healthium Medtech from an affiliate fund advised by Apax Partners. Healthium develops, manufactures and sells a broad range of surgical products globally. KKR said it will make...
Copyright 2023-2026 - www.financetom.com All Rights Reserved